Wolkowitz OM, Lupien SJ, Bigler ED (June 2007). "The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity". Neurocase. 13 (3): 189–200. doi:10.1080/13554790701475468. PMID17786779. S2CID39340010.
Weber S, Habel U, Amunts K, Schneider F (2008). "Structural brain abnormalities in psychopaths-a review". Behavioral Sciences & the Law. 26 (1): 7–28. doi:10.1002/bsl.802. PMID18327824.
Yanovski, Jack A.; Cutler, Gordon B. (1994). "Glucocorticoid Action and the Clinical Features of Cushing's Syndrome". Endocrinology and Metabolism Clinics of North America. 23 (3). Elsevier BV: 487–509. doi:10.1016/s0889-8529(18)30080-x. ISSN0889-8529. PMID7805650.
Arnaldi, G.; Angeli, A.; Atkinson, A. B.; Bertagna, X.; Cavagnini, F.; Chrousos, G. P.; Fava, G. A.; Findling, J. W.; Gaillard, R. C.; Grossman, A. B.; Kola, B.; Lacroix, A.; Mancini, T.; Mantero, F.; Newell-Price, J.; Nieman, L. K.; Sonino, N.; Vance, M. L.; Giustina, A.; Boscaro, M. (2003). "Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement". The Journal of Clinical Endocrinology & Metabolism. 88 (12). The Endocrine Society: 5593–5602. doi:10.1210/jc.2003-030871. ISSN0021-972X. PMID14671138.
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (October 2001). "Rapid reversal of psychotic depression using mifepristone". Journal of Clinical Psychopharmacology. 21 (5): 516–521. doi:10.1097/00004714-200110000-00009. PMID11593077. S2CID3067889.
Caimari F, Valassi E, Garbayo P, Steffensen C, Santos A, Corcoy R, Webb SM (February 2017). "Cushing's syndrome and pregnancy outcomes: a systematic review of published cases". Endocrine. 55 (2): 555–563. doi:10.1007/s12020-016-1117-0. PMID27704478. S2CID19349163.
Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, et al. (August 2009). "Hypercoagulable state in Cushing's syndrome: a systematic review". The Journal of Clinical Endocrinology and Metabolism. 94 (8): 2743–2750. doi:10.1210/jc.2009-0290. PMID19454584.
Wolkowitz OM, Lupien SJ, Bigler ED (June 2007). "The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity". Neurocase. 13 (3): 189–200. doi:10.1080/13554790701475468. PMID17786779. S2CID39340010.
Weber S, Habel U, Amunts K, Schneider F (2008). "Structural brain abnormalities in psychopaths-a review". Behavioral Sciences & the Law. 26 (1): 7–28. doi:10.1002/bsl.802. PMID18327824.
Yanovski, Jack A.; Cutler, Gordon B. (1994). "Glucocorticoid Action and the Clinical Features of Cushing's Syndrome". Endocrinology and Metabolism Clinics of North America. 23 (3). Elsevier BV: 487–509. doi:10.1016/s0889-8529(18)30080-x. ISSN0889-8529. PMID7805650.
Arnaldi, G.; Angeli, A.; Atkinson, A. B.; Bertagna, X.; Cavagnini, F.; Chrousos, G. P.; Fava, G. A.; Findling, J. W.; Gaillard, R. C.; Grossman, A. B.; Kola, B.; Lacroix, A.; Mancini, T.; Mantero, F.; Newell-Price, J.; Nieman, L. K.; Sonino, N.; Vance, M. L.; Giustina, A.; Boscaro, M. (2003). "Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement". The Journal of Clinical Endocrinology & Metabolism. 88 (12). The Endocrine Society: 5593–5602. doi:10.1210/jc.2003-030871. ISSN0021-972X. PMID14671138.
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (October 2001). "Rapid reversal of psychotic depression using mifepristone". Journal of Clinical Psychopharmacology. 21 (5): 516–521. doi:10.1097/00004714-200110000-00009. PMID11593077. S2CID3067889.
Caimari F, Valassi E, Garbayo P, Steffensen C, Santos A, Corcoy R, Webb SM (February 2017). "Cushing's syndrome and pregnancy outcomes: a systematic review of published cases". Endocrine. 55 (2): 555–563. doi:10.1007/s12020-016-1117-0. PMID27704478. S2CID19349163.
Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, et al. (August 2009). "Hypercoagulable state in Cushing's syndrome: a systematic review". The Journal of Clinical Endocrinology and Metabolism. 94 (8): 2743–2750. doi:10.1210/jc.2009-0290. PMID19454584.
"Cushing's Syndrome". National Endocrine and Metabolic Diseases Information Service (NEMDIS). July 2008. Archived from the original on 10 February 2015. Retrieved 16 March 2015.
Wolkowitz OM, Lupien SJ, Bigler ED (June 2007). "The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity". Neurocase. 13 (3): 189–200. doi:10.1080/13554790701475468. PMID17786779. S2CID39340010.
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (October 2001). "Rapid reversal of psychotic depression using mifepristone". Journal of Clinical Psychopharmacology. 21 (5): 516–521. doi:10.1097/00004714-200110000-00009. PMID11593077. S2CID3067889.
Caimari F, Valassi E, Garbayo P, Steffensen C, Santos A, Corcoy R, Webb SM (February 2017). "Cushing's syndrome and pregnancy outcomes: a systematic review of published cases". Endocrine. 55 (2): 555–563. doi:10.1007/s12020-016-1117-0. PMID27704478. S2CID19349163.
"Cushing's Syndrome". National Endocrine and Metabolic Diseases Information Service (NEMDIS). July 2008. Archived from the original on 10 February 2015. Retrieved 16 March 2015.
Yanovski, Jack A.; Cutler, Gordon B. (1994). "Glucocorticoid Action and the Clinical Features of Cushing's Syndrome". Endocrinology and Metabolism Clinics of North America. 23 (3). Elsevier BV: 487–509. doi:10.1016/s0889-8529(18)30080-x. ISSN0889-8529. PMID7805650.
Arnaldi, G.; Angeli, A.; Atkinson, A. B.; Bertagna, X.; Cavagnini, F.; Chrousos, G. P.; Fava, G. A.; Findling, J. W.; Gaillard, R. C.; Grossman, A. B.; Kola, B.; Lacroix, A.; Mancini, T.; Mantero, F.; Newell-Price, J.; Nieman, L. K.; Sonino, N.; Vance, M. L.; Giustina, A.; Boscaro, M. (2003). "Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement". The Journal of Clinical Endocrinology & Metabolism. 88 (12). The Endocrine Society: 5593–5602. doi:10.1210/jc.2003-030871. ISSN0021-972X. PMID14671138.